Nisha Rathode (Editor)

Charles Brenton Huggins

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Citizenship
  
Canadian / American

Name
  
Charles Huggins

Fields
  
Physiology


Charles Brenton Huggins wwwnobelprizeorgnobelprizesmedicinelaureates

Born
  
September 22, 1901 Halifax, Nova Scotia (
1901-09-22
)

Institutions
  
University of Michigan, University of Chicago

Alma mater
  
Acadia University Harvard University

Known for
  
prostate cancer hormones

Notable awards
  
Nobel Prize for Physiology or Medicine (1966) Gairdner Foundation International Award (1966)

Died
  
January 12, 1997, Chicago, Illinois, United States

Education
  
Acadia University, Harvard University, Harvard Medical School

Awards
  
Nobel Prize in Physiology or Medicine

Charles Brenton Huggins | Wikipedia audio article


Charles Brenton Huggins (September 22, 1901 – January 12, 1997) was a Canadian-American physician, physiologist and cancer researcher at the University of Chicago specializing in prostate cancer. He was awarded the 1966 Nobel Prize for Physiology or Medicine for discovering in 1941 that hormones could be used to control the spread of some cancers. This was the first discovery that showed that cancer could be controlled by chemicals.

Contents

Early life and education

Charles Brenton Huggins Charles Brenton Huggins Biography Childhood Life Achievements

Huggins was born in Halifax, Nova Scotia, Canada. He graduated from Acadia University with a BA degree in 1920. He went on to study medicine at Harvard Medical School and received his MD degree in 1924. He served his internship and residency in general surgery with Frederick A. Coller at the University of Michigan.

Work

Huggins established a method to measure the effect hormone changes have on prostatic function. He found out that castration or estrogen administration led to glandular atrophy, which could be reversed by re-administration of androgen. In 1941 the beneficial effect of androgen ablation on metastatic prostate cancer was realised when Huggins and Clarence Hodges treated patients by either castration or estrogen therapy. They monitored the prostate size and therapeutic efficacy by measuring serum Prostatic acid phosphatase levels and concluded that androgenic activity in the body influences prostate cancer, at least with respect to serum phosphatase. Huggins was the first to use a systemic approach to treat prostate cancer.

Huggins was awarded the Nobel Prize in Physiology or Medicine in 1966.

Huggins died 1997 in Chicago, Illinois at the age of 95 years. His wife died in 1983.

References

Charles Brenton Huggins Wikipedia